Cargando…
Protein Arginine Methyltransferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling
Protein arginine methyltransferase 1 (PRMT1) is the most predominant PRMT and is type I, meaning it generates monomethylarginine and asymmetric dimethylarginine. PRMT1 has functions in oxidative stress, inflammation and cancers, and modulates diverse diseases; consequently, numerous trials to develo...
Autores principales: | Kim, Eunji, Jang, Jiwon, Park, Jae Gwang, Kim, Kyung-Hee, Yoon, Keejung, Yoo, Byong Chul, Cho, Jae Youl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246892/ https://www.ncbi.nlm.nih.gov/pubmed/32357521 http://dx.doi.org/10.3390/ijms21093058 |
Ejemplares similares
-
Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems
por: Zhang, Pengcheng, et al.
Publicado: (2020) -
The Role of Protein Arginine Methyltransferases in Inflammatory Responses
por: Kim, Ji Hye, et al.
Publicado: (2016) -
Identification
of a Protein Arginine Methyltransferase
7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor
por: Feoli, Alessandra, et al.
Publicado: (2023) -
Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023) -
Arginine methyltransferase CARM1/PRMT4 regulates endochondral ossification
por: Ito, Tatsuo, et al.
Publicado: (2009)